Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: Proposal for new guidelines-Reference-Cited by-同舟云学术

Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: Proposal for new guidelines

Published:2005 Issue:1 Volume:116 Page:122-129
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bais Aagje G.,Rebolj Matejka,Snijders Peter J.F.,de Schipper Frits A.,van der Meulen Dries A.J.,Verheijen René H.M.,Voorhorst Feja,van Ballegooijen Marjolein,Meijer Chris J.L.M.,Helmerhorst Theo J.M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference38 articles.

1. POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: Design, methods and baseline data of 44,102 women

2. De praktijk van het bevolkingsonderzoek naar baarmoederhalskanker in Nederland in 2001: rapport in het kader van de landelijke evaluatie van het bevolkingsonderzoek naar baarmoederhalskanker (LEBA): Deel 3, 2003.

3. Management guidelines for women with normal colposcopy after low grade cervical abnormalities: population study

4. Natural History of Cervical Intraepithelial Neoplasia

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort;International Journal of Cancer;2018-10-31

2. Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens;Journal of Virological Methods;2013-04

3. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions;Cochrane Database of Systematic Reviews;2013-03-28

4. HPV Has Left the Building—the Absence of Detectable HPV DNA and the Presence of R Allele/S for the P72R Polymorphism in theTP53Gene May Call for More Aggressive Therapeutic Approach in HPV-Associated Tumours;Biotechnology & Biotechnological Equipment;2013-01

5. Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer;Vaccine;2012-11